In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs.

Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery / Quagliarini, Erica; Renzi, Serena; Digiacomo, Luca; Giulimondi, Francesca; Sartori, Barbara; Amenitsch, Heinz; Tassinari, Valentina; Masuelli, Laura; Bei, Roberto; Cui, Lishan; Wang, Junbiao; Amici, Augusto; Marchini, Cristina; Pozzi, Daniela; Caracciolo, Giulio. - In: PHARMACEUTICS. - ISSN 1999-4923. - 13:8(2021), pp. 1-12. [10.3390/pharmaceutics13081292]

Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery

Erica Quagliarini
Primo
;
Serena Renzi;Luca Digiacomo;Francesca Giulimondi;Valentina Tassinari;Laura Masuelli;Daniela Pozzi
Penultimo
;
Giulio Caracciolo
Ultimo
2021

Abstract

In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs.
2021
lipid nanoparticles; microfluidics; transfection efficiency; lipofectamine
01 Pubblicazione su rivista::01a Articolo in rivista
Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery / Quagliarini, Erica; Renzi, Serena; Digiacomo, Luca; Giulimondi, Francesca; Sartori, Barbara; Amenitsch, Heinz; Tassinari, Valentina; Masuelli, Laura; Bei, Roberto; Cui, Lishan; Wang, Junbiao; Amici, Augusto; Marchini, Cristina; Pozzi, Daniela; Caracciolo, Giulio. - In: PHARMACEUTICS. - ISSN 1999-4923. - 13:8(2021), pp. 1-12. [10.3390/pharmaceutics13081292]
File allegati a questo prodotto
File Dimensione Formato  
Quagliarini_Microfluidic_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.61 MB
Formato Adobe PDF
1.61 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1616584
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 23
social impact